Your email has been successfully added to our mailing list.

×
0 0 -0.0425339366515837 -0.00542986425339357 -0.00497737556561081 -0.00452488687782806 -0.0180995475113122 0.00139366515837093
Stock impact report

Acasti announces initiation of strategic alternative process [Seeking Alpha]

Acasti Pharma, Inc. - Class A (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
Company Research Source: Seeking Alpha
Acasti Pharma(NASDAQ:ACSTcommencedThe company has engaged Oppenheimer as its financial advisor to assist in the process.In the meantime, the company and its clinical advisors plan to complete the full data analyses as contemplated in the Statistical Analysis Plan for TRILOGY 2, including the secondary and exploratory endpoints, and the pooling of the data from TRILOGY 1 and 2. Show less Read more
Impact Snapshot
Event Time:
ACST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ACST alerts
Opt-in for
ACST alerts

from News Quantified
Opt-in for
ACST alerts

from News Quantified